دورية أكاديمية
Infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society
| العنوان: | Infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society |
|---|---|
| المؤلفون: | Papeix, Caroline, Donze, Cécile, Lebrun-Frénay, Christine, The Société Francophone de La Sclérose En Plaques, French Group For Recommendations In Multiple Sclerosis, Laplaud, D., Thouvenot, Eric, Ayrignac, Xavier, Pourcher-Martinez, V., Zéphir, H., de Seze, J., Michel, L., Bensa, C., Cara-Dalliere, C., Guen-Noc, A.M., Casez, O., Maarouf, A., Bourre, B., Kwiatkowski, A., Cohen, M., Maillart, E., Collongues, N., Louapre, C., Androdias, G., Guegen, A., Audoin, B., Mattey, G., Bernady, P., Faucheux, J.M., Labauge, Pierre, Meckies, C., Stankoff, B., Tourniaire, P., Dinh, A., Guennoc, A.M., Durnad-Dubief, F., Wiertlewski, S., Derache, N., Le Page, E., Pittion, S., Vukusic, S., Clavelou, P., Heinzlef, O., Colamarino, R., Planque, E., Rico, A., Sheiber Nogueira, C., de Seze, M., Ciron, J., Alchaar, H., Bensmail, D., Biotti, D., Branger, P., Brochet, B., Castan, B., Creange, A., Creisson, E., Debroucker, T., Depaz, R., Douay, X., Dulau, C., Faucher, M., Fournier, M., Fromont, A., Gallien, P., Gout, O., Grimaud, J., Hervé, Y., Kerbrat, A., Kremer, L., Lanotte, L., Magy, L., Mania, A., Maurousset, A., Moisset, X., Montcuquet, A., Moreau, T., Morel, N., Patry, I., Peaureaux, D., Pouget, M.C., Ruet, A., Saint-Val, C., Stahl, J.P., Taithe, F., Tattevin, P., Vaillant, M., Vuoto, F. |
| المساهمون: | CHU Pitié-Salpêtrière AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), CHU Nice Cimiez, Hôpital Cimiez Nice (CHU), Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Institut de Génomique Fonctionnelle (IGF), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier), Cellules Souches, Plasticité Cellulaire, Médecine Régénératrice et Immunothérapies (IRMB), Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier Universitaire Strasbourg (CHU Strasbourg), Les Hôpitaux Universitaires de Strasbourg (HUS), Centre Hospitalier Universitaire de Rennes CHU Rennes = Rennes University Hospital Ponchaillou, CHU Trousseau Tours, Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Centre Hospitalier Universitaire CHU Grenoble (CHUGA), Centre de résonance magnétique biologique et médicale (CRMBM), Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)-Centre National de la Recherche Scientifique (CNRS), Centre d'Exploration Métabolique par Résonance Magnétique Hôpital de la Timone - APHM (CEMEREM), Hôpital de la Timone CHU - APHM (TIMONE)-Centre de résonance magnétique biologique et médicale (CRMBM), Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)-Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)-Centre National de la Recherche Scientifique (CNRS), Aix Marseille Université (AMU), Centre National de la Recherche Scientifique (CNRS), CHU Rouen, Normandie Université (NU), Centre Hospitalier Universitaire de Nice (CHU Nice), Hospices Civils de Lyon (HCL), Assistance Publique - Hôpitaux de Marseille (APHM), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Université de Montpellier (UM), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Centre Hospitalier Henri Duffaut (Avignon), CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN), CHU Clermont-Ferrand, Centre hospitalier intercommunal de Poissy/Saint-Germain-en-Laye - CHIPS Poissy, Centre Hospitalier Antibes - Juan-les-Pins, Centre Hospitalier Emile Durkheim Epinal (CH Epinal / CHED), CHU Bordeaux, Centre d’Investigation Clinique 1429 Garches (CIC 1429), Hôpital Raymond Poincaré AP-HP -Institut National de la Santé et de la Recherche Médicale (INSERM), Clinique Francheville Périgueux, CHI Créteil, Centre Hospitalier de Saint-Denis Ile-de-France, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), CHU Limoges, Centre Hospitalier Annecy-Genevois Saint-Julien-en-Genevois |
| المصدر: | ISSN: 0035-3787 ; Revue Neurologique ; https://hal.science/hal-03652381Test ; Revue Neurologique, 2021, 177 (8), pp.980-994. ⟨10.1016/j.neurol.2021.04.011⟩. |
| بيانات النشر: | HAL CCSD Elsevier Masson |
| سنة النشر: | 2021 |
| المجموعة: | Aix-Marseille Université: HAL |
| مصطلحات موضوعية: | Immuno-active treatment, Infections, Multiple sclerosis, Prevention, MESH: Consensus, MESH: Humans, MESH: Immunization Schedule, MESH: Immunosuppressive Agents, MESH: Multiple Sclerosis, MESH: Recurrence, MESH: Systematic Reviews as Topic, [SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC] |
| الوصف: | International audience ; Introduction: Viral, bacterial, or fungal infections are suspected of triggering multiple sclerosis (MS) and promoting relapses of the disease and are likely to be promoted by immune-active treatments. This raises questions about the infectious workup and preventive treatment of these infections prior to their initiation.Objectives: To establish recommendations on infections and MS. Provide information to patients and healthcare professionals on the minimal infectious workup to be performed in an MS patient at diagnosis and prior to initiation of immuno-active therapy in MS.Methods: The recommendation attempts to answer four main questions about infections and MS. The French Group for Recommendations in Multiple Sclerosis (France4MS) did a systematic review of articles from PubMed and universities databases (from January 1975 to June 2020), using the RAND/UCLA formalized consensus method. The RAND/UCLA method has been developed to synthesize the scientific literature and expert opinions on health care topics and was used for reaching a formal agreement. Twenty-three experts contributed to the detailed review and a group of 63 multidisciplinary health professionals validated the final version of 36 recommendations.Results: It is recommended that MS patients undergo a minimal infectious workup, check their vaccination status at diagnosis, and repeat it during follow-up and before starting immunotherapy. Screening and preventive treatment of viral (group Herpes virus, HPV, JCV, HCV, HBV), bacterial (mycobacteria) and fungal (Cryptococcus) infections is recommended prior to the initiation of certain immuno-active MS therapies.Discussion and conclusions: At diagnosis of MS and prior to the choice of therapeutic strategy, it is recommended to update the vaccination schedule of MS patients in reference to the HCSP vaccination schedule and the SFSEP recommendations. Before starting immunosuppressive treatment, it is recommended to inform patients of the risks of infections and to look for a ... |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| العلاقة: | info:eu-repo/semantics/altIdentifier/pmid/34303537; hal-03652381; https://hal.science/hal-03652381Test; PUBMED: 34303537; WOS: 000717497200035 |
| DOI: | 10.1016/j.neurol.2021.04.011 |
| الإتاحة: | https://doi.org/10.1016/j.neurol.2021.04.011Test https://hal.science/hal-03652381Test |
| رقم الانضمام: | edsbas.256AFEDB |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.neurol.2021.04.011 |
|---|